Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Author Correction: Towards an arthritis flare-responsive drug delivery system.

Joshi N, Yan J, Levy S, Bhagchandani S, Slaughter KV, Sherman NE, Amirault J, Wang Y, Riegel L, He X, Rui TS, Valic M, Vemula PK, Miranda OR, Levy O, Gravallese EM, Aliprantis AO, Ermann J, Karp JM.

Nat Commun. 2018 May 11;9(1):1954. doi: 10.1038/s41467-018-04346-x.

2.

Towards an arthritis flare-responsive drug delivery system.

Joshi N, Yan J, Levy S, Bhagchandani S, Slaughter KV, Sherman NE, Amirault J, Wang Y, Riegel L, He X, Rui TS, Valic M, Vemula PK, Miranda OR, Levy O, Gravallese EM, Aliprantis AO, Ermann J, Karp JM.

Nat Commun. 2018 Apr 3;9(1):1275. doi: 10.1038/s41467-018-03691-1. Erratum in: Nat Commun. 2018 May 11;9(1):1954.

3.

Gut microbiota induce IGF-1 and promote bone formation and growth.

Yan J, Herzog JW, Tsang K, Brennan CA, Bower MA, Garrett WS, Sartor BR, Aliprantis AO, Charles JF.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7554-E7563. Epub 2016 Nov 7.

4.

RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.

O'Brien W, Fissel BM, Maeda Y, Yan J, Ge X, Gravallese EM, Aliprantis AO, Charles JF.

Arthritis Rheumatol. 2016 Dec;68(12):2889-2900. doi: 10.1002/art.39837.

5.

IL4RA on lymphatic endothelial cells promotes T cell egress during sclerodermatous graft versus host disease.

Urso K, Alvarez D, Cremasco V, Tsang K, Grauel A, Lafyatis R, von Andrian UH, Ermann J, Aliprantis AO.

JCI Insight. 2016 Aug 4;1(12). pii: e88057.

6.

Sex-Specific Protection of Osteoarthritis by Deleting Cartilage Acid Protein 1.

Ge X, Ritter SY, Tsang K, Shi R, Takei K, Aliprantis AO.

PLoS One. 2016 Jul 14;11(7):e0159157. doi: 10.1371/journal.pone.0159157. eCollection 2016.

7.

Anion Exchanger 2 Regulates Dectin-1-Dependent Phagocytosis and Killing of Candida albicans.

Urso K, Charles JF, Shull GE, Aliprantis AO, Balestrieri B.

PLoS One. 2016 Jul 8;11(7):e0158893. doi: 10.1371/journal.pone.0158893. eCollection 2016.

8.

NFAT restricts osteochondroma formation from entheseal progenitors.

Ge X, Tsang K, He L, Garcia RA, Ermann J, Mizoguchi F, Zhang M, Zhou B, Zhou B, Aliprantis AO.

JCI Insight. 2016 Apr;1(4):e86254.

9.

Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.

Sargent JL, Li Z, Aliprantis AO, Greenblatt M, Lemaire R, Wu MH, Wei J, Taroni J, Harris A, Long KB, Burgwin C, Artlett CM, Blankenhorn EP, Lafyatis R, Varga J, Clark SH, Whitfield ML.

Arthritis Rheumatol. 2016 Aug;68(8):2003-15. doi: 10.1002/art.39658.

10.

Cryopreserved Amniotic Suspension for the Treatment of Knee Osteoarthritis.

Vines JB, Aliprantis AO, Gomoll AH, Farr J.

J Knee Surg. 2016 Aug;29(6):443-50. doi: 10.1055/s-0035-1569481. Epub 2015 Dec 18.

PMID:
26683979
11.

The intestinal microbiome and skeletal fitness: Connecting bugs and bones.

Charles JF, Ermann J, Aliprantis AO.

Clin Immunol. 2015 Aug;159(2):163-9. doi: 10.1016/j.clim.2015.03.019. Epub 2015 Apr 1. Review.

12.

Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis.

Ritter SY, Collins J, Krastins B, Sarracino D, Lopez M, Losina E, Aliprantis AO.

Arthritis Res Ther. 2014 Oct 7;16(5):456. doi: 10.1186/s13075-014-0456-6.

13.

Osteoclasts: more than 'bone eaters'.

Charles JF, Aliprantis AO.

Trends Mol Med. 2014 Aug;20(8):449-59. doi: 10.1016/j.molmed.2014.06.001. Epub 2014 Jul 6. Review.

14.

NFATc1 and NFATc2 repress spontaneous osteoarthritis.

Greenblatt MB, Ritter SY, Wright J, Tsang K, Hu D, Glimcher LH, Aliprantis AO.

Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19914-9. doi: 10.1073/pnas.1320036110. Epub 2013 Nov 18.

15.

Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues.

Ritter SY, Subbaiah R, Bebek G, Crish J, Scanzello CR, Krastins B, Sarracino D, Lopez MF, Crow MK, Aigner T, Goldring MB, Goldring SR, Lee DM, Gobezie R, Aliprantis AO.

Arthritis Rheum. 2013 Apr;65(4):981-92. doi: 10.1002/art.37823.

16.

SLC4A2-mediated Cl-/HCO3- exchange activity is essential for calpain-dependent regulation of the actin cytoskeleton in osteoclasts.

Coury F, Zenger S, Stewart AK, Stephens S, Neff L, Tsang K, Shull GE, Alper SL, Baron R, Aliprantis AO.

Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2163-8. doi: 10.1073/pnas.1206392110. Epub 2013 Jan 22.

17.

The immune pathogenesis of scleroderma: context is everything.

Greenblatt MB, Aliprantis AO.

Curr Rheumatol Rep. 2013 Jan;15(1):297. doi: 10.1007/s11926-012-0297-8. Review.

18.

Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function.

Charles JF, Hsu LY, Niemi EC, Weiss A, Aliprantis AO, Nakamura MC.

J Clin Invest. 2012 Dec;122(12):4592-605. doi: 10.1172/JCI60920. Epub 2012 Nov 1.

19.

The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption.

Charles JF, Coury F, Sulyanto R, Sitara D, Wu J, Brady N, Tsang K, Sigrist K, Tollefsen DM, He L, Storm D, Aliprantis AO.

Bone. 2012 Nov;51(5):902-12. doi: 10.1016/j.bone.2012.08.113. Epub 2012 Aug 16.

20.

Graft versus host disease in the bone marrow, liver and thymus humanized mouse model.

Greenblatt MB, Vrbanac V, Tivey T, Tsang K, Tager AM, Aliprantis AO.

PLoS One. 2012;7(9):e44664. doi: 10.1371/journal.pone.0044664. Epub 2012 Sep 5. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/e413f2a1-5767-4c82-9e27-dd556155f124. Vbranac, Vladimir [corrected to Vrbanac, Vladimir].

21.

Control of bone resorption in mice by Schnurri-3.

Wein MN, Jones DC, Shim JH, Aliprantis AO, Sulyanto R, Lazarevic V, Poliachik SL, Gross TS, Glimcher LH.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8173-8. doi: 10.1073/pnas.1205848109. Epub 2012 May 9.

22.

Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets.

Greenblatt MB, Sargent JL, Farina G, Tsang K, Lafyatis R, Glimcher LH, Whitfield ML, Aliprantis AO.

Am J Pathol. 2012 Mar;180(3):1080-94. doi: 10.1016/j.ajpath.2011.11.024. Epub 2012 Jan 11.

23.

Transient muscle paralysis degrades bone via rapid osteoclastogenesis.

Aliprantis AO, Stolina M, Kostenuik PJ, Poliachik SL, Warner SE, Bain SD, Gross TS.

FASEB J. 2012 Mar;26(3):1110-8. doi: 10.1096/fj.11-196642. Epub 2011 Nov 28.

24.

Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression.

Broen JC, Dieude P, Vonk MC, Beretta L, Carmona FD, Herrick A, Worthington J, Hunzelmann N, Riemekasten G, Kiener H, Scorza R, Simeon CP, Fonollosa V; Spanish Systemic Sclerosis Group, Carreira P, Ortego-Centeno N, Gonzalez-Gay MA, Airo' P, Coenen MJ, Tsang K, Aliprantis AO, Martin J, Allanore Y, Radstake TR.

J Rheumatol. 2012 Jan;39(1):112-8. doi: 10.3899/jrheum.110235. Epub 2011 Nov 1.

25.

Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.

Jones D, Glimcher LH, Aliprantis AO.

J Clin Invest. 2011 Jul;121(7):2534-42. doi: 10.1172/JCI46262. Epub 2011 Jul 1.

26.

Transcriptional regulation of bone and joint remodeling by NFAT.

Sitara D, Aliprantis AO.

Immunol Rev. 2010 Jan;233(1):286-300. doi: 10.1111/j.0105-2896.2009.00849.x. Review.

27.

NFATc1 in inflammatory and musculoskeletal conditions.

Aliprantis AO, Glimcher LH.

Adv Exp Med Biol. 2010;658:69-75. doi: 10.1007/978-1-4419-1050-9_8. Review.

PMID:
19950017
28.

HCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and function.

Wu J, Glimcher LH, Aliprantis AO.

Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):16934-9. doi: 10.1073/pnas.0808763105. Epub 2008 Oct 29.

29.

NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism.

Aliprantis AO, Ueki Y, Sulyanto R, Park A, Sigrist KS, Sharma SM, Ostrowski MC, Olsen BR, Glimcher LH.

J Clin Invest. 2008 Nov;118(11):3775-89. doi: 10.1172/JCI35711. Epub 2008 Oct 9.

30.

NFATc1 balances quiescence and proliferation of skin stem cells.

Horsley V, Aliprantis AO, Polak L, Glimcher LH, Fuchs E.

Cell. 2008 Jan 25;132(2):299-310. doi: 10.1016/j.cell.2007.11.047.

31.

Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13.

Aliprantis AO, Wang J, Fathman JW, Lemaire R, Dorfman DM, Lafyatis R, Glimcher LH.

Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2827-30. Epub 2007 Feb 16.

32.

Toll-like receptor-2 transduces signals for NF-kappa B activation, apoptosis and reactive oxygen species production.

Aliprantis AO, Weiss DS, Zychlinsky A.

J Endotoxin Res. 2001;7(4):287-91.

PMID:
11717583
33.

Release of Toll-like receptor-2-activating bacterial lipoproteins in Shigella flexneri culture supernatants.

Aliprantis AO, Weiss DS, Radolf JD, Zychlinsky A.

Infect Immun. 2001 Oct;69(10):6248-55.

34.

The apoptotic signaling pathway activated by Toll-like receptor-2.

Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A.

EMBO J. 2000 Jul 3;19(13):3325-36.

35.

Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2.

Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A.

Science. 1999 Jul 30;285(5428):736-9.

36.

The regulation of apoptosis by microbial pathogens.

Moss JE, Aliprantis AO, Zychlinsky A.

Int Rev Cytol. 1999;187:203-59. Review.

PMID:
10212981
37.

Do macrophages kill through apoptosis?

Aliprantis AO, Diez-Roux G, Mulder LC, Zychlinsky A, Lang RA.

Immunol Today. 1996 Dec;17(12):573-6. Review.

PMID:
8991289
38.

In vivo apoptosis in Shigella flexneri infections.

Zychlinsky A, Thirumalai K, Arondel J, Cantey JR, Aliprantis AO, Sansonetti PJ.

Infect Immun. 1996 Dec;64(12):5357-65.

Supplemental Content

Loading ...
Support Center